Clorox Files 8-K on Shareholder Votes and Financials

Ticker: CLX · Form: 8-K · Filed: 2025-11-20T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, financial-reporting

Related Tickers: CLX

TL;DR

CLX filed an 8-K for shareholder votes & financials. Keep an eye on updates.

AI Summary

On November 19, 2025, The Clorox Company filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The filing was made on November 20, 2025, and pertains to events on November 19, 2025. The company's principal executive offices are located at 1221 Broadway, Oakland, California.

Why It Matters

This filing indicates important corporate actions and financial reporting by Clorox, which could influence investor decisions and market perception.

Risk Assessment

Risk Level: low — This is a routine filing for corporate actions and financial reporting, not indicating immediate operational or financial distress.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates a submission of matters to a vote of security holders, but the specific details of these matters are not provided in the provided text.

What is the purpose of filing financial statements and exhibits with this 8-K?

The filing states that financial statements and exhibits are being filed, typically to provide updated financial information or supporting documentation related to the reported events.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on November 19, 2025.

What is the principal executive office address for The Clorox Company?

The principal executive office address for The Clorox Company is 1221 Broadway, Oakland, California 94612-1888.

What is the Commission File Number for The Clorox Company?

The Commission File Number for The Clorox Company is 001-07151.

From the Filing

0001206774-25-000747.txt : 20251120 0001206774-25-000747.hdr.sgml : 20251120 20251120164254 ACCESSION NUMBER: 0001206774-25-000747 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251119 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251120 DATE AS OF CHANGE: 20251120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 251503614 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 8-K 1 clx4562621-8k.htm CURRENT REPORT false 0000021076 0000021076 2025-11-19 2025-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): November 19, 2025     THE CLOROX COMPANY (Exact name of registrant as specified in its charter)   Delaware 1-07151 31-0595760 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation)   Identification No.)   1221 Broadway , Oakland , California 94612-1888 (Address of principal executive offices) (Zip code)   ( 510 ) 271-7000 (Registrant's telephone number, including area code)   Not applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock - $1.00 par value CLX New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.07 Submission of Matters to a Vote of Security Holders.   (a) On November 19, 2025, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders.     (b) The shareholders (1) elected all of the Company’s nominees for director, (2) approved the compensation of the Company’s named executive officers on an advisory basis, and (3) ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.   The final voting results on each of the matters submitted to a vote are as f

View on Read The Filing